No Matches Found
No Matches Found
No Matches Found
BGI Genomics Co., Ltd.
BGI Genomics Hits Day Low of CNY 42.15 Amid Price Pressure
BGI Genomics Co., Ltd. faced a significant stock decline, reflecting ongoing financial challenges. The company has experienced a notable decrease in stock performance over various timeframes, including a substantial annual drop. Financial metrics indicate persistent difficulties, with negative operating cash flow and a prolonged period of unprofitability.
BGI Genomics Hits Day Low of CNY 44.70 Amid Price Pressure
BGI Genomics Co., Ltd. faced a notable stock decline on March 3, 2026, amid ongoing challenges, including 16 consecutive quarters of negative results and a significant drop in operating profit over five years. The company's market capitalization stands at CNY 20,164 million as it navigates a tough sector.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
